A Phase 2/3 Trial Of The Efficacy And Safety

Project: Research project

Project Details

Description

A Phase 2/3 Trial Of The Efficacy And Safety Of Bardoxolone Methyl In Patients With Alport Syndrome
StatusActive
Effective start/end date12/1/166/30/21

Funding

  • Reata Pharmaceuticals, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.